Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04458948 · ClinicalTrials.gov registry record · Phase 2
Non-comparative Trial of the Combination of HCQ and AZI in the Treatment of ICU Patients
A Phase 2 study, sponsored by University of New Mexico.
- Terminated
- Registry status
- Phase 2
- Development phase
- 28
- Enrollment target
NCT04458948 is a Phase 2 study that was terminated before completion, run by University of New Mexico. The registered enrollment target is 28 participants.
The verdict
NCT04458948, a Phase 2 study, was terminated before completion, sponsored by University of New Mexico.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 28 participants
- Enrollment target
Study Summary
This research is designed as an open-label,non-comparative prospective trial.
Interventions
- DRUG Azithromycin
- DRUG Hydroxychloroquine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2020-03-24 |
| Est. Completion | 2020-08-28 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04458948
The ClinicalTrials.gov registry entry for NCT04458948 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of New Mexico, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Azithromycin is the first listed.
NCT04458948 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04458948 about?
NCT04458948 is a clinical study titled "Non-comparative Trial of the Combination of HCQ and AZI in the Treatment of ICU Patients". This research is designed as an open-label,non-comparative prospective trial.
What is the current status of trial NCT04458948?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 28 participants. The study started on 2020-03-24. Estimated completion is 2020-08-28.
What interventions are being tested in trial NCT04458948?
The interventions under investigation include: Azithromycin (DRUG), Hydroxychloroquine (DRUG).
Who is sponsoring clinical trial NCT04458948?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.